Annual Drug Patent Expirations for LINZESS Linzess is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Abbvie drug LINZESS appeared first on…
Annual Drug Patent Expirations for MYFEMBREE Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent expiration for Myovant Sciences drug MYFEMBREE appea…
New patent expiration for Myovant Sciences drug MYFEMBREE Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
This chart shows the pharmaceutical companies with the most patents in Australia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pa…
Which pharmaceutical companies have the most drug patents in Australia? Read Post »
Annual Drug Patent Expirations for QVAR+REDIHALER Qvar Redihaler is a drug marketed by Norton Waterford and is included in one NDA. It is available from three suppliers. There are thirteen…
The post New patent for Norton Waterford drug QVAR REDIHALER a…
New patent for Norton Waterford drug QVAR REDIHALER Read Post »
Annual Drug Patent Expirations for BELRAPZO Belrapzo is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Eagle Pharms drug BELRAPZO appeared first on DrugPat…
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Beigene drug BRUKINSA appeared first on DrugPate…
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are seven patents…
The post New patent for Abbvie drug ORIAHNN (COPACKAGE…
EVOCLIN (clindamycin phosphate) Mylan Patent: 7,374,747 Expiration: Jan 23, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug P…
Drug Patent Expirations for the Week of January 21, 2024 Read Post »
Annual Drug Patent Expirations for ORILISSA Orilissa is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are ten patents protecting…
The post New patent for Abbvie drug ORILISSA appeared first on DrugPatent…